Thrombogenic Mechanisms of Antiphospholipid Antibodies

Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? [see comments]

1993 • 496 citations

Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies [see comments]

1994 • 364 citations

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

1996 • 354 citations

Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function.

1992 • 288 citations

Development of an ELISA for Autoantibodies to Prothrombin Showing their Prevalence in Patients with Lupus Anticoagulants

1995 • 215 citations

Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C.

1994 • 177 citations

Surface-dependent hemostasis.

1992 • 167 citations

Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: A possible mechanism of thrombosis

1993 • 148 citations

Effect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice

1994 • 141 citations

Receptors for immunoglobulin g molecular diversity and implications for disease

1995 • 139 citations

On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies.

1995 • 132 citations

Antiphospholipid antibodies and thrombosis. A consequence, coincidence, or cause?

1993 • 119 citations

Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine

1995 • 114 citations

An update on clinical and basic aspects of the protein C anticoagulant pathway

1995 • 107 citations

Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases.

1996 • 93 citations

Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid

1996 • 86 citations

Randomized prospective trial comparing the native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant therapy

1990 • 78 citations

Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles

1996 • 62 citations

Phosphatidylethanolamine Induces High Affinity Binding Sites for Factor VIII on Membranes Containing Phosphatidyl-L-serine

1995 • 59 citations

Phosphatidylethanolamine Induces Specific Conformational Changes in the Kininogens Recognizable by Antiphosphatidylethanolamine Antibodies

1996 • 55 citations

Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis

1991 • 30 citations

Autoantibodies to Thrombomodulin: Development of an Enzyme Immunoassay and a Survey of their Frequency in Patients with the Lupus Anticoagulant

1992 • 26 citations

Lupus anticoagulants and thrombosis: the role of phospholipids.

1997 • 19 citations

Cited By (0)

Loading...